Search
Sunday 9 August 2015
  • :
  • :
Latest Update

Pre-Market News Report on: etlife (NYSE:MET), Kite Pharma (NASDAQ:KITE), Astoria Financial (NYSE:AF), ServiceNow (NYSE:NOW)

On Wednesday, Metlife Inc (NYSE:MET)’s shares declined -0.06% to $55.52.

MetLife, Inc. (MET) declared that Cindy Tang will join the company as its Vice President and Head of Communications for the Asia region. Cindy will be based out of MetLife’s Asia region office in Hong Kong and will start with the company on August 20, 2015. Cindy will report to Jeanmarie McFadden, Executive Vice President and Chief Communications Officer for MetLife. At the same time, she will become a member of MetLife’s Asia Leadership Group and will work closely with Christopher Townsend, President of Asia for MetLife.

In this role, Cindy will offer planned direction in corporate communications to support senior leaders in Asia for the various and ambitious business strategies across the region. She will also spearhead all communications initiatives.

MetLife, Inc. provides life insurance, annuities, employee benefits, and asset administration products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. It operates in six segments: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America; Asia; and Europe, the Middle East and Africa. The company provides variable, universal, term, and whole life products; individual disability income products; personal lines property and casualty insurance, counting private passenger automobile, homeowners, and personal excess liability insurance; and variable and fixed annuities for asset accumulation and distribution needs, in addition to mutual funds and other securities products.

Kite Pharma Inc (NASDAQ:KITE)’s shares gained 4.03% to $76.50.

Kite Pharma, Inc. (KITE) and bluebird bio, Inc. (BLUE) declared that they have reached a partnershipagreement to co-develop and co-commercialize second generation T cell receptor (TCR) product candidates directed against the human papillomavirus type 16 E6 (HPV-16 E6) oncoprotein incorporating gene editing and lentiviral technologies. bluebird bio has a platform comprised of lentiviral gene delivery and gene editing capabilities, with a focus on rare diseases and cancer immunotherapies. Kite has a broad existing pipeline of TCR product candidates and will continue to develop its existing and wholly-owned TCR programs directed against high-risk HPV, which are unaffected by this collaboration, counting HPV-16 E6 TCR, presently in a Phase I study, and HPV-16 E7 TCR. The partnership brings together the powerful technologies and capabilities of these two leading immunotherapy companies.

Under the terms of the agreement, both companies will jointly develop and commercialize second generation TCR product candidates directed against the HPV-16 E6 oncoprotein, incorporating gene editing to efficiently modify certain genes to enhance T cell function. In addition, the companies will explore using lentiviral vectors to optimize delivery of HPV-16 E6 TCRs into patient T cells.

Kite will lead the program in the U.S., and bluebird bio will have the option to lead the program in the European Union. Both companies will share overall costs, counting research and development and sales and marketing expenses, and profits will be equally split between the companies. Additionally, Kite will have a co-promotion option in the European Union, and bluebird will have a co-promotion option in the U.S.

Kite Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. The company is developing a pipeline of engineered autologous cell therapy-based product candidates for the treatment of solid and hematological malignancies. Its lead product candidate is KTE-C19, a chimeric antigen receptors (CAR)-based therapy that is in Phase 1-2a clinical trials for the treatment of patients with refractory diffuse large B cell lymphoma. The company is also developing T cell receptors-based therapies, which targets SSX2, NY-ESO-1, and MAGE antigens in various cancers.

At the end of Wednesday’s trade, Astoria Financial Corp (NYSE:AF)‘s shares surged 0.74% to $16.23.

Astoria Bank, Long Island’s fourth largest bank by deposit market share and the second largest community bank headquartered in New York, recently declared it will hold the 16th annual Kids Tools for School drive, starting on August 1. The bank will collect school supplies and donations, at all branch locations, to purchase supplies for local families who struggle to afford these items as their children start the new school year.

Since its inception, the program has expanded greatly and evolved, largely through meaningful partnerships counting those with the Girl Scouts organizations of both Nassau and Suffolk Counties and Village Office Supply, a local office supply company that volunteers its services for transporting and warehousing donated supplies.

Astoria Financial Corporation operates as the holding company for Astoria Bank that provides various financial products and services to individuals and businesses in the United States. The company accepts various deposit products, counting passbook and statement savings accounts, money market accounts, NOW and demand deposit accounts, and certificates of deposit. I

ServiceNow Inc (NYSE:NOW), ended its Wednesday’s trading session with 0.64% gain, and closed at $78.41.

ServiceNow® (NOW), the enterprise cloud company, declared the financial results for its second quarter 2015.

Second Quarter 2015 Results:

  • Revenues of $246.7 million, an enhance of 48% year-over-year and 59% in constant currency.
  • GAAP net loss of $61.9 million, or a loss of $0.40 per basic and diluted share, contrast to a GAAP net loss of $50.4 million, or a loss of $0.35 per basic and diluted share, in the second quarter of 2014.
  • Non-GAAP net income of $7.3 million, or income of $0.05 per basic share and $0.04 per diluted share, contrast to a non-GAAP net loss of $9.4 million, or a loss of $0.07 per basic and diluted share, in the second quarter of 2014.
  • Calculated billings were $281.4 million, increasing 50% year-over-year and 62% in constant currency.
  • Added 21 net new Global 2000 customers, bringing the total to 566.
  • For a reconciliation of these GAAP and non-GAAP financial measures, please see the table entitled “Results of Operations GAAP to Non-GAAP Reconciliation” comprised of at the end of this release.

ServiceNow, Inc. provides cloud-based solutions that define, structure, manage, and automate services to enterprise operations in North America, Europe, the Middle East, Africa, the Asia Pacific, and other countries. The company offers service administration solutions, counting incident administration, problem administration, change administration, request administration, and cost administration, in addition to service catalog and knowledge base; and IT, HR, facilities, and field service administration solutions.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *